Navigation Links
CCBR-SYNARC Expands Electronic Data Capture Capabilities
Date:10/30/2009

SAN FRANCISCO, Oct. 30 /PRNewswire/ -- CCBR-SYNARC, the world's leading provider of medical image analysis, biochemical marker, and clinical research center services to the pharmaceutical and biotechnology industries, announced the expansion of its Electronic Data Capture ("EDC") capabilities for use in imaging clinical trials.

SYNARC has been using EDC to support global imaging trials since 2004. With the release of the enhanced SynarcConnect(SM) service, SYNARC has further improved its data and image transfer capabilities to meet the demanding standards of its in-house radiologists, scientific experts, and global sponsors.

"This latest release of our EDC system will improve the sponsor and investigator site experience in interacting with our service delivery teams," stated Herve Girsault, CEO. "As we constantly strive to achieve excellence in our service levels, I'm pleased with the results and reception of the enhanced SynarcConnect(SM) service."

The complexity of moving images and data from thousands of investigator sites across the globe to SYNARC's in-house readers is streamlined through the use of Web-based electronic data capture. Investigator sites only need access to the Internet to benefit from the electronic transmittal forms, study documents and electronic image transfer capabilities. Sponsors benefit from the decreased time between image acquisition and analysis, relief from costs associated with courier services, and efficient access to real-time study information via SynarcConnect(SM)'s Web-based reporting. Investigator sites also benefit from faster cycle times between image acquisition and centralized image quality review, resulting in improved protocol adherence and overall image quality.

About SYNARC

CCBR-SYNARC is the recognized world leader in medical image analysis, biochemical marker and clinical research center services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development.

SYNARC imaging services integrate critical aspects of clinical-trial design and execution, from protocol design to regulatory liaison on behalf of our clients. Our expert radiologists and scientists are innovators in all aspects of medical image analysis and have pioneered many methods used in today's clinical trials. Synarc has five imaging centers around the world providing global delivery capabilities in support of our clients' clinical development programs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091030/SF02009LOGO)

    Media Contact:
    Joy Valderrama
    415 817-8919
    joy.valderrama@synarc.com

www.synarc.com

SOURCE CCBR-SYNARC


'/>"/>
SOURCE CCBR-SYNARC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs
2. Quark Pharmaceuticals Expands International Patent Protection for Compounds Targeting the RTP801 Gene
3. Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement
4. Hologic Expands Healthcare Investment in Asia
5. NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
6. Raptor Pharmaceutical Expands Board of Directors
7. Intermountain McKay-Dee Hospital Center Expands Real-Time Locating Solution From Versus Technology, Inc.
8. Lupin Expands Branded Play
9. CEL-SCI Expands H1N1 Flu Virus Work
10. OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
11. Vision Inspection Systems Specialist Acquire Automation Expands Employee Base, Launches New Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):